申请人:Byondis B.V.
公开号:US20220119392A1
公开(公告)日:2022-04-21
The present invention relates to novel antifolate linker-drugs, conjugates comprising such antifolate linker-drugs, and the use thereof in the treatment of diseases, such as cancer, autoimmune and infectious diseases, optionally in combination with other therapeutic agents.